|
시장보고서
상품코드
2052311
펩타이드 치료제 시장 : 제품 유형별, 용도별, 투여 경로별, 지역별Peptide Therapeutics Market, By Product Type, By Application, By Route of Administration, and By Region |
||||||
펩타이드 치료제 시장은 2026년에 538억 6,930만 달러로 추정되며, 2033년까지 853억 7,680만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.8%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 538억 6,930만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 6.80% | 2033년 시장 규모 예측: | 853억 7,680만 달러 |
펩타이드 의약품의 개발은 새로운 제조, 변형 및 분석 기술을 통해 비약적인 발전을 이루었습니다. 펩타이드는 화학적 및 생물학적 방법을 사용하여 생성 및 변형되며, 펩타이드 고유의 단점을 극복하고 이 분야의 지속적인 발전을 가능하게 하는 새로운 설계 및 전달 전략이 채택되고 있습니다. 심장대사, 면역학, 피부과학, 종양학 등 다양한 치료 영역을 아우르는 다양한 천연 및 변형 펩타이드가 확보되어 연구가 진행되고 있습니다. 펩타이드 의약품 개발은 21세기에 접어들면서 새로운 시대를 맞이했고, 이후 구조 생물학, 재조합 생물학적 제제 및 새로운 합성 및 분석 기술의 발전으로 그 과정이 눈에 띄게 가속화되었습니다. 펩타이드 신약개발, 약물 설계, 펩타이드 합성, 구조 변형 및 활성 평가를 포함한 정교한 펩타이드 의약품 개발 시스템이 구축되어 있습니다.
치료용 펩타이드는 일반적으로 500-5000Da의 분자량을 가지고 있으며, 아미노산으로 구성된 독특한 의약품군입니다.
시장 역학
시장 진입 기업들은 생체적합성과 강력한 치료 효과를 높여 대상 환자 맞춤형 솔루션을 제공하기 위해 새롭고 혁신적인 펩타이드 치료제를 개발하고 있습니다. 암, 심혈관질환, 당뇨병의 유병률 증가는 예측 기간 동안 펩타이드 치료제 시장의 성장을 견인할 것으로 예상됩니다.
시장 내 주요 기업들이 제품 포트폴리오를 확대하기 위해 제휴 등 유기적 성장 전략을 채택하는 움직임이 가속화되고 있으며, 이는 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 예를 들어, 2023년 1월 세계 최대 제약사 릴리와 세계 헬스케어 기업 머크는 펩타이드 표적 약물전달 관련 제휴를 발표하고, 바이오 제약사 PeptiDream 인수를 위해 협력하기로 했습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개변수(회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 세계 펩타이드 치료제 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서는 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 펩타이드 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 펩타이드 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 펩타이드 치료제 시장 : 제품 유형별, 2021-2033년
제5장 세계의 펩타이드 치료제 시장 : 용도별, 2021-2033년
제6장 세계의 펩타이드 치료제 시장 : 투여 경로별, 2021-2033년
제7장 세계의 펩타이드 치료제 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSMPeptide Therapeutics Market is estimated to be valued at USD 53,869.3 Mn in 2026 and is expected to reach USD 85,376.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 53,869.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.80% | 2033 Value Projection: | USD 85,376.8 Mn |
Peptide drug development has grown immensely due to new manufacturing, modification, and analytical techniques. Peptides are generated and modified using both chemical and biological methods, along with new design and delivery strategies that overcomes the inherent drawbacks of peptide and enables continued progress in this field. A wide variety of natural and modified peptides have been obtained and studied covering multiple therapeutic area such as cardio metabolic, immunology and dermatology, oncology, etc. Peptide drug development entered a new era with the advent of the 21st century, since then advances in structural biology, recombinant biologics, and new synthetic and analytic technologies have significantly accelerated the process. A sophisticated system of peptide drug development has been established, including peptide drug discovery, drug design, peptide synthesis, structural modification, and activity evaluation.
Therapeutic peptides are a unique class of pharmaceuticals composed of an ordered series of amino acids, typically with molecular weights between 500 and 5000 Da.
Market Dynamics
Market players are developing novel and innovative peptide therapeutics to provide tailored solutions for target patients, by enhancing biocompatibility and potent therapeutic efficacy. Increasing prevalence of cancer, cardiovascular diseases, and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period.
Increasing adoption of organic growth strategies such as collaborations by key players in the market in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2023, Lilly, one of the world's largest pharmaceutical companies, and Merck, a global healthcare company, announced their partnership for peptide-targeted drug delivery, collaborating to acquire PeptiDream which is a biopharmaceutical company.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global peptide therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health, Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide therapeutics market
Peptide Therapeutics Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Branded Peptide
- Generic Peptide
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Cancer
- Cardiovascular diseases
- Metabolic diseases
- Respiratory diseases
- Infectious diseases
- Others
- Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Oral Administration
- Parenteral Administration
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Teva Pharmaceutical Industries Ltd
- Novo Nordisk A/S
- OPKO Health Inc.
- Lilly
- Hanmi Pharm.Co.
- Sanofi
- Circle Pharma
- Pfizer Inc.
- Novartis AG
- PeptiDream Inc.
- Amgen Inc.
- AstraZeneca
- Bachem Holding AG
- CordenPharma International
- Ipsen Pharma
- Merck KGaA
- PolyPeptide Group
- Bayer AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- PORTER's Analysis
- Pricing Analysis (2022)
4. Global Peptide Therapeutics Market, By Product Type, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Branded Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Generic Peptide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
5. Global Peptide Therapeutics Market, By Application, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Metabolic Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Peptide Therapeutics Market, By Route of Administration, 2021-2033, (US$ Million)
- Oral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Parenteral Administration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Peptide Therapeutics Market, By Region, 2021-2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OPKO Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lilly
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hanmi Pharm.Co.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Circle Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PeptiDream Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bachem Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CordenPharma International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PolyPeptide Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
